Psychotomimesis Mediated by κ Opiate Receptors
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The κ opioid agonists are analgesics that seem to be free of undesired morphine-like effects. Their dysphoric actions observed with the κ agonist cyclazocine are thought to be mediated by an action at σ-phencyclidine receptors. The benzomorphan κ agonist MR 2033 is inactive at σ-phencyclidine receptors. In male subjects, the opiate-active (-)-isomer, but not the (+)-isomer, elicited dose-dependent dysphoric and psychotomimetic effects that were antagonized by naloxone. Thus, κ opiate receptors seem to mediate psychotomimetic effects. In view of the euphorigenic properties of μ agonists, our results imply the existence of opposed opioid systems affecting emotional and perceptual experiences.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“agonism of κ-opioid receptors were shown to produce depression-like symptoms in humans (Pfeiffer et al., 1986).”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Pfeiffer et al., 1986
In the citing paper
“Nonetheless, the three receptor types have different behavioral domains, with MOR and DOR mediating generally positive motivation and affect, while KOR mediates generally negative motivation and aversion (Pfeiffer et al 1986; Shippenberg et al 1987; Pecina and Berridge 2000; McLaughlin et al 2003; for reviews see Van Ree et al 2000; Le Merrer et al 2009).”
From The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction (2012) · cites this paper as Pfeiffer et al 1986
In the citing paper
“Kappa receptor agonists induce anxiogenic and dysphoric effects in humans (141-143) and depressive-like behavior in animals (i.e., increased immobility in the forced swim test) (144, 145).”
From A brain-centric model of suicidal behavior (2020) · cites this paper as [141]
Citations
Cites
(1976) · Medical Entomology and Zoology · Cited by 8,899
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992
Pharmacologic effects of CI‐581, a new dissociative anesthetic, in man
Domino, E. F., Chodoff, P., & Corssen, G. (1965) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196563279 · Cited by 748
Martin, W. R. (1983) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06637-2 · Cited by 648
Thrills in response to music and other stimuli
Goldstein, A. (1980) · Physiological Psychology · doi:10.3758/bf03326460 · Cited by 522
Mucha, R. F., & Herz, A. (1985) · Psychopharmacology · doi:10.1007/bf00432213 · Cited by 510
Self-citationThe binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties
Magnan, J., Paterson, S. J., Tavani, A., & Kosterlitz, H. W. (1982) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00495865 · Cited by 509
A CLASSIFICATION OF OPIATE RECEPTORS THAT MEDIATE ANTINOCICEPTION IN ANIMALS
TYERS, M. B. (1980) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1980.tb07041.x · Cited by 341
Opiate receptor binding sites in human brain
Pfeiffer, A., Pasi, A., Mehraein, P., & Herz, A. (1982) · Brain Research · doi:10.1016/0006-8993(82)91150-7 · Cited by 298
Self-citationPhencyclidine (angel dust)/sigma "opiate" receptor: visualization by tritium-sensitive film.
Quirion, R., Hammer, R. P., Herkenham, M., & Pert, C. B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5881 · Cited by 254
Research works printed but not linked: 6
- Jasinski, D. R., Drug Addiction 1: 216 (1977).
- MARTIN, W.R., PHARMACOL REV 35: 283 (1984).
- MARTIN, W.R., SUBSTANCE AND ALCOHOL ACTIONS/MISUSE 1: 269 (1980).
- Shearman, G. T., Drug Discrimination: Application in CNS Pharmacology: 37 (1982).
- VAUPEL, D.B., FAILURE OF NALTREXONE (NTX) TO ANTAGONIZE PHENCYCLIDINE (PCP) AND THE OPIOID SKF-10047 (SKF) IN THE DOG, FEDERATION PROCEEDINGS 41: 1333 (1982).
- Zerssen, D. V., Assessment of Depression: 270 (1985).
Cited by
Items 801–900 of 956
Sauer, M. E. (2014) · mediaTUM (Technical University of Munich) · Cited by 1
Donahue, R. J. (2016) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 1
Genetic and Pharmacologic Studies Towards Prevention of opioid use disorder
Kaski, S. W. (2019) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.4124 · Cited by 1
Andrews, M. M. (2019) · ResearchWorks at the University of Washington (University of Washington) · Cited by 1
Sedation and Analgesia in the Critically Ill Neurology and Neurosurgery Patient
Hemstreet, M. K., Suárez, J. I., & Mirski, M. A. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-660-7_12 · Cited by 1
Behavioural Pharmacology of Novel Kappa Opioid Compounds
Morani, A. S. (2011) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17011409 · Cited by 1
McCurdy, C. R., & Prisinzano, T. E. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc251.pub2 · Cited by 1
Schuckit, M. A. (1989) · Springer eBooks · doi:10.1007/978-1-4757-0767-0_6 · Cited by 1
Rasakham, K. (2008) · Digital Repository Service (Northeastern University) · doi:10.17760/d1001679x · Cited by 1
Sigma Receptors, PCP Receptors and the Developing Nervous System
London, E. D., & Zukin, S. R. (1993) · Springer eBooks · doi:10.1007/978-94-011-1544-5_11 · Cited by 1
Neural mechanisms underlying a conditioned place preference induced by morphine
Olmstead, M. C. (1995) · eScholarship@McGill (McGill) · doi:10.82308/12301 · Cited by 1
Potential Utility of Kappa Ligands in the Treatment of Mood Disorders
Carlezon, W. A., & Cohen, B. M. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-197-0_22 · Cited by 1
Borgkvist, A. (2008) · Figshare
The Interaction of Pain and Morphine on Analgesia, Locomotion, and Cognitive Functioning
Baiamonte, B. A. (2010) · ScholarWorks @ The University of New Orleans (The University of New Orleans)
Ioja, E. (2008) · SZTE Repository of Dissertations (University of Szeged)
Behavioral and neurobiological consequences of intermittent exposure to addictive drugs.
Rothwell, P. E. (2010) · University of Minnesota Digital Conservancy (University of Minnesota)
Motivational Systems: Rewards and Incentive Value
LaLumiere, R. T., & Kalivas, P. W. (2012) · Wiley eBooks · doi:10.1002/9781118133880.hop203014
Role of Kappa-Opioid Receptors in Stress-Induced Behaviors
Veer, V. S., & Victoria, A. (2013) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Magnusson, K. (2009) · Uppsala University Publications (Uppsala University)
Shen, S., & Ingenito, A. J. (1999) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(99)00041-5
Hohmann, A. G., Clement, R. W., & Walker, J. M. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90337-9
Tripelennamine interactions with the pscyhotomimetic sigma agonist N-allylnormetazocine
Vaupel, D. B. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90414-0
Intravenous drugs in anaesthesia
Hamilton, N. M. (1997) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.7.11.1321
Allgemeine Kinetik zentraler Schmerzmittel — mit besonderer Berücksichtigung der Opioide
Waldvogel, H. H. (1996) · Springer eBooks · doi:10.1007/978-3-642-97649-0_9
Doyon, W. M. (2005) · Texas ScholarWorks (Texas Digital Library)
Identification and characterization of diterpene synthases in the salvinorin A biosynthetic pathway
Mitchell, R. (2012) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/26417
The Synthesis and Pharmacological Evaluation of Salvinorin A Analogues as Opioid Receptor Probes
Lovell, K. M. (2011) · KU ScholarWorks (The University of Kansas)
Design, synthesis and metabolism of arodyn analogs
Dresner, K. N. (2009) · KU ScholarWorks (The University of Kansas)
Bradykinin Ligands and Receptors Involved in Neuropathic Pain
Hall, S. M. (2015) · UA Campus Repository (The University of Arizona)
Biological basis of anxiety and strategies for pharmacological innovation
Emilien, G., Dinan, T. G., Lepola, U. M., & Durlach, C. (2002) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8157-9_2
Epigenetic Dysregulations in the Brain of Human Alcoholics : Analysis of Opioid Genes
Bazov, I. (2016) · DiVA (Digitala Vetenskapliga Arkivet)
Chang, K., Yi, S.-P., & Shen, Y. (2015) · Springer eBooks · doi:10.1007/978-3-319-25495-1_2
Ableitner, A. (1991) · Springer eBooks · doi:10.1007/978-3-642-46660-1_23
Yates, J. W. (2003) · OhioLink ETD Center (Ohio Library and Information Network)
The Impact of Repeated Stress on Neuropeptidergic Regulation of Monoamine Systems
Lemos, J. C. (2012) · ResearchWorks at the University of Washington (University of Washington)
Schindler, A. G. (2012) · ResearchWorks at the University of Washington (University of Washington)
Molecular Regulation of Opioid Receptor Signaling
Schattauer, S. S. (2012) · ResearchWorks at the University of Washington (University of Washington)
Regulation of the endogenous opioid system by acute nicotine and nicotine withdrawal
McCarthy, M. J. (2004) · OhioLink ETD Center (Ohio Library and Information Network)
Investigations Of Salvinorin A: Synthetic Isolation, Quantification, And In Vivo Characteristics
Caspers, M. (2013) · KU ScholarWorks (University of Kansas)
Characterisation and use of radiotracers in studies of inflammatory tissue and opioid binding sites
Lawrence, A. J. (1990) · Loughborough University Institutional Repository (Loughborough University)
Targeting Opioid Receptors for Innovative Antidepressant Therapies: Rediscovering the Opioid Cure
Darcq, E., Chung, P. C. S., Kieffer, B. L., & Lutz, P.-É. (2016) · Springer eBooks · doi:10.1007/978-81-322-2803-5_38
Kappa opioid receptor modulation of neurotransmission in the amygdala
Crowley, N. (2015) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/emjn-0f63
Wong, J. T. (2016) · Deep Blue (University of Michigan)
Snyder, L. M., Omori, Y., Hachisuka, J., Adelman, P. C., Hu, Z., Fulton, S. A., Sypeck, E., Huang, H., Cai, X., Scherrer, G., et al. (2017) · Journal of Pain · doi:10.1016/j.jpain.2017.02.369
Mechanisms of Opioid Receptor Desensitization
Kuhar, J. R. (2015) · ResearchWorks at the University of Washington (University of Washington)
Proliferation in an Animal Model of Depression and Controls
Bjrnebekk, A., Mathé, A. A., & Brené, S. (2006)
Involvement of nitric oxide signaling mechanisms underlying opioid tolerance
Laría, P., & Patricia, I. (2015) · Communities in ADDI (Universidad del Pais Vasco)
Kappa Opioid Regulation of Dopamine in Dysphoria and Addiction
Ehrich, J. M. (2015) · ResearchWorks at the University of Washington (University of Washington)
Orexin modulation of ventral tegmental area dopamine neurons
Baimel, C. (2016) · cIRcle (University of British Columbia) · doi:10.14288/1.0303473
Effects of Corticotrophin Releasing Factor on Ventral Tegmental Area Neurons
Driscoll, J. R. (2017) · eScholarship (California Digital Library)
Molecular Mechanisms of Reward and Aversion
Klawonn, A. M. (2017) · Linköping University medical dissertations · doi:10.3384/diss.diva-143459
Narayanan, S. (1996) · OhioLink ETD Center (Ohio Library and Information Network)
Novel KOR Antidepressant and Analgesic Strategies
Cohen, J. (2018) · ResearchWorks at the University of Washington (University of Washington)
White, K. L. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/q73z-g116
Atigari, D. V. (2019) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17136338.v1
Robinson, J. E. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/kg9d-bw74
Ma, H. (2017) · KU ScholarWorks (The University of Kansas)
Navarro, M., & Míriam (2019) · Repositori digital de la UPF (Universitat Pompeu Fabra)
Mohamud, A. (2019) · uO Research (University of Ottawa) · doi:10.20381/ruor-24185
Étude des partenaires impliqués dans le trafic du récepteur opioïde delta vers la membrane plasmique
Bergeron, F. (2020) · Knowledge UdeS (Institutional Deposit of the University of Sherbrooke)
The role of the endogenous opioid system in hyperalgesia associated with negative affect
Ferdousi, M. I. (2020) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/17817
Cross, S. J. (2019) · eScholarship (California Digital Library)
The Role of Kappa Opioid Receptor Signaling in Injury-Free Pain
Nation, K. (2018) · UA Campus Repository (The University of Arizona)
Robble, M. A. (2017) · e-Publications@Marquette (Marquette University)
STUDIES ON NEURITE OUTGROWTH AND RECEPTOR PHOSPHORYLATION FOLLOWING KAPPA OPIOID RECEPTOR ACTIVATION
Chiu, Y.-T. (2016) · TUScholarShare (Temple University)
Investigating the Acute and Chronic Effects of Known and Novel Opioid Ligands
Sears, B. F. (2021) · Deep Blue (University of Michigan) · doi:10.7302/1332
Dissecting the Role of Amygdala Circuits in the Control of Fear Extinction and Alcohol Drinking
Bloodgood, D. W. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/vq86-g486
The role of Proteasome in the development, maintenance and management of Chronic Pain
Rullo, L. (2021) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.48676/unibo/amsdottorato/9795
σ receptors: Putative links between nervous, endocrine and immune systems
Su, T. (1991) · Springer eBooks · doi:10.1007/978-3-642-77200-9_13
(2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816793-9.00001-3
Bazov, I., & Bakalkin, G. Y. (2016) · Epigenetics and human health · doi:10.1007/978-3-319-29901-3_3
Platz, W. E., Böning, J., Wesemann, W., Weiner, N., Hartmann, A., Deckert, J., & Gleiter, C. H. (1992) · Springer eBooks · doi:10.1007/978-3-7091-3793-2_5
Lovell, K. M., Frankowski, K. J., Stahl, E. L., Slauson, S. R., Yoo, E., Prisinzano, T. E., Aubé, J., & Bohn, L. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00157
Berridge, K. C. (2008) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1102183.558183
(2013) · Circulation · doi:10.1161/cir.0b013e31828cee7b
Abadey, A. A. (2023) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.23639313
THESIS: "ΟΠΙΟΕΙΔΕΙΣ ΥΠΟΔΟΧΕΙΣ: in vitro ΑΠΟΤΙΜΗΣΗ ΕΝΕΡΓΟΤΗΤΑΣ ΝΕΩΝ ΒΙΟΕΝΕΡΓΩΝ ΜΟΡΙΩΝ"
ARGYROU, M. (2023) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.7903561
Tunley, S. (2024) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.25201913
Flammia, R., Huang, B., Pagare, P. P., Onge, C. M. S., Abebayehu, A., Gillespie, J. C., Mendez, R. E., Selley, D. E., Dewey, W. L., & Zhang, Y. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107489
Adli Toksikoloji Klinik, Nöropsikiyatrik ve Postmortem Değerlendirme
Işık, C., & Öztuna, Ş. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3156
Activity-Related Transcription: Role in Addiction
Rounds, J. S., Matheos, D. P., & Wood, M. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-68550-7_12
Chapter 3. Historical Review Opioid Receptors
Snyder, S. H., & Pasternak, G. W. (2008) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615377794.lg04
Tong, M., Sun, W. F., Dong, P., Wang, J., Gu, X., & Cao, Z. (2025) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70181
Discovery of Highly Potent G Protein-Biased Bisamide Kappa Opioid Receptor Agonists
Taylor, K. S., Czekner, K. M., Harland, A. A., Ma, H., Dang, V. Q., Koehn, K. R. K., Frankowski, K. J., Stahl, E. L., Cameron, M. D., Bohn, L., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01108
Chapter 8 Pharmacology and molecular biology of opioid receptors
Pettit, H. O., Lee, P. H. K., & Chang, K.-J. (1997) · Principles of medical biology · doi:10.1016/s1569-2582(97)80070-0
Klonierung und pharmakologische Charakterisierung der equinen Opioidrezeptoren
Muehlhaupt, M. (2018) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.22684
The Mu and Delta Opioid Receptors: Mixed Efficacy Ligands and Receptor Trafficking.
Anand, J. P. (2013) · Deep Blue (University of Michigan)
Liu, H., Huang, R., Zhuo, Z., Zhang, X. L., Wu, L., Guo, Z., Wen, F., An, L., Yuan, H., Zhang, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26061413
REGULATION OF DOPAMINE TERMINAL RELEASE IN THE NUCLEUS ACCUMBENS: IMPLICATIONS FOR ALCOHOL ADDICTION
Melchior, J. R. (2017) · WakeSpace Scholarship (Wake Forest University)
Torino, D. (2010) · IRIS Research product catalog (Sapienza University of Rome)
The importance of endogenous opioids in feeding behavior
Ghule, A. (2018) · bonndoc (University of Bonn)
The role of endogenous opioids in pain, pleasure, and pain-pleasure interactions
Price, R. C. (2016) · eScholarship@McGill (McGill) · doi:10.82308/53476
Études des mécanismes physiopathologiques cognitifs des troubles addictifs
Lalanne, L. (2016) · Serveur des thèses de l'Université de Strasbourg (University of Strasbourg)
Paprotny, M. (2003) · Dokumentenrepositorium der RUB (Ruhr University Bochum)
Reichard, K. (2020) · ResearchWorks at the University of Washington (University of Washington)
Metadata
- Authors
- Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M.
- Affiliations
- LMU Klinikum (DE)
- Boehringer Ingelheim (Germany) (DE)
- Max Planck Society (DE)
- Max Planck Institute of Psychiatry (DE)
- ORCID
- Pfeiffer, Andreas
- Venue
- Science
- Published
- 1986-08-15
- Volume
- 233
- Issue
- 4765
- Pages
- 774-776
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2032643119
- Cited by
- 857
- References
- 30
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 23 · 2023: 17 · 2022: 18 · 2021: 38 · 2020: 42 · 2019: 21 · 2018: 27 · 2017: 24 · 2016: 37 · 2015: 38 · 2014: 30 · 2013: 35 · 2012: 41
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- psychotomimetic effects, kappa opioid receptor, kappa opioid receptor agonists, cyclazocine, naloxone antagonism, stereoisomers, mu-opioid receptor agonists, euphoria, analgesia
- MeSH terms
- Adult, Anxiety, Benzomorphans, Humans, Male, Middle Aged, Morphinans, Naloxone, Personality Tests, Phencyclidine, Receptors, Opioid, Receptors, Opioid, kappa
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.